Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Insilico Medicine Announces Global R&D Collaboration with Lilly
Tuesday, March 31, 2026Insilico Medicine a clinicalstage biotechnology company powered by generative artificial intelligence AI and automation today announced a drug discovery collaboration with Eli Lilly and Company Lilly
Building the Future of Biotechnology — UK Biotech Day 2026
Thursday, March 26, 2026UK Biotech Day taking place on May will be held at the Radisson Hotel Conference Centre London Heathrow The event is set to spotlight the strength global relevance and collaborative spirit of the UKs biotechnology ecosystem
Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics
Thursday, March 26, 2026Alteogen Inc KOSDAQ announced today that it has entered into an exclusive license agreement with Biogen Inc for the development and commercialization of subcutaneous SC formulations of biologics utilizing ALTB powered by Alteogens Hybrozyme technolo...
GlycoNex Inc. and Nippon Kayaku Co., Ltd. Enter Collaboration to Advance Next-Generation ADC Candidate GNX201-ADC
Tuesday, March 24, 2026GlycoNex Inc a clinicalstage biotechnology company focused on the development of glycandirected cancer immunotherapies today announced that it has entered into a collaboration agreement with Nippon Kayaku Co Ltd Nippon Kayaku to advance GNXADC
Insitro and Bristol Myers Squibb Collaboration Expanded with Nomination of New Targets
Monday, March 23, 2026Insitro the AI therapeutics company built on causal biology today announced the expansion of its strategic collaboration with Bristol Myers Squibb NYSE BMY to advance a broadened portfolio of therapeutic programs for amyotrophic lateral sclerosis ALS
Dsm-firmenich launches ModulaSENSE® Bitter – a novel taste modulation technology to enhance drug palatability
Friday, March 20, 2026Dsmfirmenich a leading innovator in nutrition health and beauty announces the launch of a new technology ModulaSENSE Bitter designed to help pharmaceutical companies improve the taste of drugs and increase patient adherence This new te
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
Wednesday, March 18, 2026Liminatus today announced plans to initiate a Phase clinical trial evaluating IBA a nextgeneration CDblocking monoclonal antibody designed to engage innate immune pathways and complement established immunooncology therapies
Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
Wednesday, March 18, 2026Polaryx Therapeutics Inc a clinicalstage biotechnology company developing diseasemodifying therapies for rare pediatric lysosomal storage disorders LSDs today announced that the US Food and Drug Administration
Samsung Bioepis and Epis NexLab Sign Research Collaboration and License Agreement with G2GBIO to Develop Novel Assets Including Long-acting Semaglutide
Tuesday, March 17, 2026Samsung Bioepis Co Ltd and Epis NexLab Co Ltd a sister company to Samsung Bioepis under Samsung Epis Holdings KRX Z today announced a research collaboration and license agreement with GGBIO
Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch
Tuesday, March 17, 2026Piramal Pharma Solutions a leading global Contract Development and Manufacturing Organization CDMO and part of Piramal Pharma Ltd NSE PPLPHARMA BSE is proud to announce the completion
